Core Viewpoint - The Hong Kong pharmaceutical sector, particularly Chinese medicine stocks, is experiencing significant market activity, with China Traditional Chinese Medicine (01177) trading between 7 and 7.8 HKD, indicating strong investor interest [1] Technical Analysis - The stock is currently in a critical triangular consolidation phase, with a short-term support level at 7.05 HKD and a strong support level at 7.00 HKD. Resistance levels are at 7.76 HKD and 7.90 HKD [1] - The stock price is above the 10-day moving average (MA10) of 7.05 HKD but is constrained by the 30-day (MA30) at 7.38 HKD and the 60-day (MA60) at 7.85 HKD, indicating a mid-term trend still in recovery [1] - Various technical indicators show mixed signals: RSI is at a neutral level of 53, momentum indicators suggest a potential bottoming out, and MACD indicates a buy signal, while overall technical indicators provide a sell signal with a strength of 8 [1] Support and Resistance Analysis - The 7.00 HKD level is identified as a crucial psychological barrier; breaching this level could trigger technical selling pressure. Conversely, breaking above 7.76 HKD could lead to a challenge of the higher target at 7.90 HKD [3] - The probability of an upward movement is estimated at 54%, with a 5-day volatility of 9.4%, suggesting good trading opportunities in the current price range [3] Derivative Market Performance - Recent performance in the options market shows strong upward movement in derivative products related to Chinese medicine stocks. For instance, on November 12, a 7.66% increase in the underlying stock led to a 30% rise in UBS call option 17735 and a 27% increase in Societe Generale call option 17698 [3] Investment Opportunities - For bullish investors, HSBC call option 18513 with a strike price of 8.77 HKD offers a leverage of 3.9 times, while Huatai call option 18530 with a strike price of 8.88 HKD provides a leverage of 4.3 times, making them attractive for cost-effective investment [6] - For bearish investors, Macquarie put option 20163 with a strike price of 6.666 HKD, despite having a lower leverage of 1.8 times, is the highest among similar products, suitable for those with a cautious outlook [6] Market Sentiment and Future Outlook - The current policy environment for the pharmaceutical sector is becoming clearer, raising questions about the valuation recovery opportunities for Chinese medicine stocks. The ability of the 7.00 HKD level to serve as a solid foundation for a new market rally is under consideration [10]

Group 1: Hang Seng Index (HSI) - The market sentiment is bearish, with investors expecting the index to range between 25,700 and 25,800 next week, while some are optimistic about a rebound above 27,000 if it holds above 26,100 this week [1] - The Hang Seng Index closed at 26,290 points, breaking through the middle line of the Bollinger Bands, indicating a neutral short-term technical signal [1] - Support levels are identified at 25,833 and 25,500, with resistance at 27,000 [1] Group 2: Tencent Holdings (00700.HK) - Tencent's stock price closed at 651.5 HKD, falling below the middle line of the Bollinger Bands, with increased trading volume indicating a less favorable situation [8] - The technical signal is summarized as a "buy" with first support at 639 HKD and second support at 619 HKD [8] Group 3: Alibaba Group (09988.HK) - Alibaba's stock price closed at 165.4 HKD, also falling below the middle line of the Bollinger Bands, with a neutral technical signal [14] - Support levels are noted at 153 HKD and 142 HKD, with potential for the price to drop below 150 HKD [14] Group 4: China Mobile (00941.HK) - China Mobile's stock price closed at 84.8 HKD, showing a notable upward trend despite the overall market decline, with a "buy" signal [21] - Resistance levels are identified at 88.2 HKD and 91 HKD [21] Group 5: China Shenhua Energy (01088.HK) - China Shenhua's stock price closed at 39.56 HKD, having broken through the upper band of the Bollinger Bands, with a "sell" signal [24] - Resistance levels are at 40.3 HKD and 41.4 HKD, with a target price of 50 HKD mentioned by investors [24] Group 6: JD.com (09618.HK) - JD.com's stock price closed at 131.8 HKD, falling below the middle line of the Bollinger Bands, indicating a neutral outlook [31] - Support levels are at 127.1 HKD and 122.5 HKD, with potential for the price to drop to 125 HKD [31]

煤炭板塊重點股兗州煤業（01171）近期走勢引發市場關注，股價在資源板塊輪動中尋找明確方向。截止14点32分，股價升4.91%，報10.48元，突破保力加通道底部。 從技術分析角度觀察，兗煤當前RSI指標處於68水準，接近超買區域但尚未完全進入，技術指標總結信號顯示"賣出"，顯示賣壓相對溫和。多個震盪指標呈 現分歧走勢，動量震盪指標發出買入信號，但變動率指標卻顯示賣出信號，這種技術面矛盾預示短期可能維持震盪格局。 在關鍵價位分析方面，兗煤當前第一支持位設於9.7元，第二支持位則在9.4元水準，這兩個價位將成為短期重要防守關口。上方阻力位方面，第一阻力位 10.7元與第二阻力位11.1元構成明顯壓力區間，特別是10.7元關口將成為多空雙方爭奪的焦點。從移動平均線系統觀察，MA10的9.75元高於MA30的9.46元和 MA60的9.09元，整體維持多頭排列格局，為股價提供技術支撐。 對於衍生產品投資者而言，在當前市況下，您更傾向於選擇低槓桿穩健型產品還是高槓桿進攻型產品？歡迎分享您對兗煤後市的看法與交易策略，別忘了關 注「港股窩輪Jenny」帳號，獲取更多港股衍生工具的最新分析與專業建議，助您在板塊輪動中把握投 ...